Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection

Cardioneuroablation is a novel approach to treat patients with recurrent vasovagal syncope (VVS), targeting the ganglionated plexi around the atria and thus reducing the vagal input to the heart. This study reports a case of drug-refractory VVS after COVID-19 infection, successfully managed with car...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Stefanos Zafeiropoulos, MD, PhD, Nicholas J. Beccarino, MD, Stavros Stavrakis, MD, PhD, Stavros Zanos, MD, PhD, Raman Mitra, MD, PhD
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2024-07-01
Цуврал:	JACC: Case Reports
Нөхцлүүд:	cardioinhibitory cardioneuroablation COVID-19 syncope vasovagal
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2666084924001669
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!